A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung CancerTaofeek K. Owonikoko, Fadlo R. Khuri, Mourad Tighiouart et al.|Clinical Cancer Research|2015Cited by 26
Abstract LB-194: Window of opportunity preoperative interrogation of mTOR pathway in patients with resectable non-small cell lung cancer (NSCLC).Taofeek K. Owonikoko, Fadlo R. Khuri, Daniel Miller et al.|Cancer Research|2013Cited by 0
Data from A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung CancerTaofeek K. Owonikoko, Fadlo R. Khuri, Suresh S. Ramalingam et al.|Unknown|2023Cited by 0
Supplementary Table S1 from A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung CancerTaofeek K. Owonikoko, Fadlo R. Khuri, Suresh S. Ramalingam et al.|Unknown|2023Cited by 0